I

IPS-Integrated Project Services, LLC

Integrated design, engineering, construction management

Industrial Analyst - Modeling and Simulation

Full-TimeUpdated on 10/23/2026Deadline 9/3/27
No salary listed
Mid
Bachelor's, Associate's
Remote in USA+1 moreMore locations: Blue Bell, PA, USA
RemoteUnited States (remote): Remote option is for candidates who are not local to any U.S. regional office.
Architecture & Civil EngineeringConstruction Management

About the job

Requirements
  • A minimum of 3 years of simulation modeling experience is required.
  • A minimum of 3 years of experience developing in Java, C, C++, or C# is required.
  • A bachelor's or associate's degree in industrial and systems engineering, systems engineering, supply chain management, logistics, or a related field from an accredited university is required.
  • Proven experience leading simulation modeling designs is required.
  • Proficiency in Microsoft Excel, Word, and PowerPoint is required.
  • The employee must be able to work at client sites in construction, process, packaging, manufacturing, research, or other non-administrative areas; the role is safety-sensitive.
Responsibilities
  • Lead simulation modeling projects with minimal supervision.
  • Discuss facility and process questions and concerns directly with client subject matter experts and IPS architects and engineers, including material flow, personnel flow, utilization, space constraints, and bottlenecks.
  • Develop and implement simulation model designs using AnyLogic to answer facility and process questions.
  • Present models and findings internally and/or to clients.
  • Work with clients and IPS staff to develop AnyLogic simulation models of material and personnel movements through facilities, resource utilization, turnaround times, equipment failures and repair times, and bottleneck identification.
  • Model processing rooms, material-handling equipment, warehouse racking, automated storage and retrieval systems, conveyor systems, shipping and receiving docks, locker rooms, airlocks, and transitions as applicable.
  • Capture and communicate baseline model data.
  • Develop what-if experiments and compare results to the baseline model.
  • Identify and communicate the data required for accurate simulations.
  • Develop a library of standard modeling elements for use in future models.
  • Contribute simulation data to Concept and Basic Design reports, including assumptions, calculations, results, and written narrative.

About the company

I

IPS-Integrated Project Services, LLC

View

IPS provides design, engineering, and construction management for complex facilities, especially in the pharmaceutical and biotech industries. Its products work by integrating these services into one team from the project’s start, coordinating planning, detailed design, procurement, and construction management to align with a client's business goals and move a project from concept to operational facility. The company differentiates itself through integrated delivery across disciplines and a global footprint (five continents), supported by growth through strategic acquisitions and Berkshire Hathaway backing, which adds financial strength and scale. IPS’s goal is to help life-science clients bring critical facilities online efficiently, with predictable cost, schedule, and quality, by delivering coordinated design, engineering, and construction management under one umbrella.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Philadelphia, Pennsylvania

Founded

1989

Get referred to IPS-Integrated Project Services, LLC

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • GE HealthCare named IPS lead on its $138 million Cork expansion in January 2025.
  • Revelio Labs counted 7,274 employees in March 2026, up 15.3% since 2023.
  • IPS added Ireland, Switzerland, and Melbourne capacity while ENR ranked it Top 150.

What critics are saying

  • Kinetic Systems won fees in March 2025, exposing IPS to subcontract disputes.
  • Glassdoor reviews in 2025 cite management, training, and work-life balance problems.
  • IPS depends on pharmaceutical capex cycles; a delayed mega-project pipeline hits utilization fast.

What makes IPS-Integrated Project Services, LLC unique

  • IPS combines design, engineering, EPCMV, and validation for one accountable delivery team.
  • Berkshire Hathaway backing gives IPS patient capital and credibility with regulated manufacturers.
  • Kneat partnership digitizes validation workflows, strengthening IPS’s end-to-end project delivery model.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Remote Work Options
  • Hybrid Work Options

Growth & Insights and Company News

6 month growth

11%

1 year growth

12%

2 year growth

12%
PR Newswire
Aug 8th, 2025
AST Names Industry Veteran Jacob Stephen as Chief Operating Officer

TACOMA, Wash., Aug. 7, 2025 /PRNewswire/ - AST is pleased to announce that Jacob Stephen will be joining the AST Team as Chief Operations Officer at the Tacoma-headquartered drug product equipment manufacturing company.

IPSDB
Mar 14th, 2025
IPS Expands Leadership in Ireland with Appointment of Karl Page

IPS expands leadership in Ireland with appointment of Karl Page.

HIT Consultant
Feb 25th, 2025
The Future Of Advanced Therapeutics: Opportunities And Challenges

Sai Bhamidipati, Pharmaceutical Regulatory Affairs ConsultantThe biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These innovative treatments offer unprecedented opportunities to address complex diseases. Yet, they also present unique regulatory and manufacturing challenges that must be navigated to bring them from the laboratory to the clinic.mRNA Vaccines: Revolutionizing Disease PreventionMessenger RNA (mRNA) vaccines have gained prominence, particularly during the COVID-19 pandemic, demonstrating the potential for rapid development and high efficacy. Unlike traditional vaccines, which utilize weakened or inactivated pathogens or their protein subunits, mRNA vaccines utilize a synthetic version of the messenger RNA to instruct cells to produce a protein that elicits an immune response. This modality allows for swift adaptation to emerging pathogens and has opened avenues for vaccines targeting various diseases, including influenza and certain types of cancers.Opportunities:Rapid Development: The cell-free, scalable nature of mRNA production enables quick responses to emerging health threats.IPSDBThe cell-free, scalable nature of mRNA production enables quick responses to emerging health threats. IPSDB Versatility: mRNA vaccines can be designed to target a wide range of therapeutic areas, including but not limited to infectious diseases, Cancer-specific antigens, and rare disease areas.Challenges:Manufacturing Complexities: Scaling up production for mass production while maintaining quality and consistency poses significant challenges

IPSDB
Sep 18th, 2024
Kneat and IPS Announce Strategic Partnership

By integrating Kneat's digital validation software with IPS' technology driven delivery approach, a new benchmark for a truly digital integrated project delivery model, from concept/requirements definition through final process qualification.

IPSDB
Jul 11th, 2024
IPS Accelerates Expansion in Switzerland with New Office and Enhanced R&D Capabilities

Additionally, Integrated Project Services, LLC is excited to announce the appointment of Pia Mueller as the new Senior Manager of Laboratory Projects.